Navigation Links
New WaveSense Presto(TM) and Pro(TM) Glucose Meters to Simplify Testing
Date:6/6/2008

SALEM, N.H., June 6 /PRNewswire/ -- The makers of the WaveSense(TM) line of blood glucose monitoring products (AgaMatrix, Inc.) announce the launch of the WaveSense Presto and WaveSense KeyNote Pro Blood Glucose Monitoring Systems (BGMS). The Presto is a no code meter with premium features that consumers can buy at a value price. The Pro is designed for use in institutional settings with added features for increased safety.

The Presto has all the market-leading features of AgaMatrix's first product, the WaveSense KeyNote(R), but does not require coding and is priced considerably less than no code products from the major brands. The system also has improved ergonomics and a brighter backlit display. Like the KeyNote, it requires a small sample size (0.5 microliters), is As Fast As 1-2-3(R), and has alternate site testing. Presto builds on the existing base of WaveSense customers that is expected to exceed 1,000,000 by this fall.

"We are extremely excited to launch our first no code product in the United States," said Dave Conn, Chief Commercial Officer. "Following the feedback we received from our users, the new Presto meets a growing market need for an affordable system that also has high accuracy and is easy to use. We are very proud of our progress and these new products are an important transition for our company as we grow. Consumers will be able to find the Presto in retail outlets this fall."

In a recent clinical study, the Presto was shown to be extremely accurate, as 93% of the results were within 10% of a lab standard*.

The WaveSense product portfolio consists of the KeyNote and KeyNote Pro, for users who want a value meter, the Presto, for users who want a no code meter, and the WaveSense Jazz(TM), for users who want a premium meter for better control. All products uniquely feature WaveSense, a new technology that personalizes each test to provide world class accuracy.

Marian Batts-Turner, MSN, RN, CDE, a leading diabetes educator who is a faculty member of the Welch Center for Prevention, Epidemiology, and Clinical Research, at Johns Hopkins University, said, "It's great to see that the company is listening to what diabetes educators and patients are asking for -- high accuracy systems that are more affordable and easier to use. This is vital for improving patient care."

About WaveSense

WaveSense is a line of products designed to improve the quality of diabetes care by using a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. The company also makes Zero-Click(TM), a diabetes data management system designed to simplify data download. Together there are six FDA-cleared products protected by a suite of more than 160 patents worldwide. For more information on or to buy WaveSense products, see http://www.wavesense.info.

* Based on an ISO 15197 system accuracy study; Type 1 & Type 2 participants, YSI reference. Result is for reference concentrations greater than or equal to 75 mg/dL. Laboratory Standard is a Yellow Springs Instrument (YSI) 2300 STAT Plus Blood Glucose Analyzer.

WaveSense; Presto; Pro; KeyNote; WaveSense Jazz; and Zero-Click are trademarks of AgaMatrix, Inc.


'/>"/>
SOURCE WaveSense
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe
2. Microsoft Dynamics CRM 4.0 Users now can include Telephony and Call Recording features by adding ConversationPRO(TM) from VoiceGate, a Division of IgeaCare Systems Inc.
3. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
4. Special supplement on self-monitoring of blood glucose in diabetes technology & therapeutics
5. Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics
6. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
7. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
8. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
9. Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
10. Notch-ing glucose into place
11. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... NY (PRWEB) , ... March 24, 2017 , ... ... scale; from third world countries to hospitals in the United States, it’s a ... conversation on the current obstacles facing infection prevention and offers strategies for the ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by NCPA ... does not obey the rules Congress has directed the CBO to follow. The CBO ... reform would restore. Yet, it estimates a reduction in employer-based coverage due to the ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... planning, and related services to families and business owners across eastern Michigan, is ... feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... Society (ONS) wanted to create a communications platform that positions them as the ... Elliance and ONS reinvented their online publication as an always-on, always-fresh news, views ...
(Date:3/24/2017)... Westchester County, NY (PRWEB) , ... March 24, 2017 , ... ... in Somers and White Plains, N.Y., is pleased to announce Westchester resident Lauren C. ... as a law clerk for the firm, will concentrate her practice in elder law, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
(Date:3/24/2017)... March 24, 2017 Today Stock-Callers.com have ... which are: Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), ... SSH ). These companies are part of the ... on Thursday, March 23 rd , 2017, with the NYSE ... of health care companies in the S&P 500 were down ...
Breaking Medicine Technology: